NanoSeptic Surface Effective Against a Variety of Pathogens
|
By HospiMedica International staff writers Posted on 02 Apr 2014 |
|
Image: A door handle coated with a NanoSeptic Surface (Photo courtesy of NanoTouch Materials).
An innovative disruptive technology provides a new tool in the fight against infection and illness of even the most dangerous pathogens.
The NanoSeptic surface, developed in the Center for Advanced Engineering and Research (CAER; Forest, VA, USA) and manufactured by NanoTouch Materials (Forest, VA, USA), is composed of antimicrobial components that are molecularly bonded on a nanoscale, providing a nonleaching, self-cleaning surface that constantly traps and kills bacteria, viruses, and fungi through a catalytic oxidation process using available light. The surfaces also eventually degrade the endotoxins the are the result of bacterial death.
The surfaces work constantly kill pathogens utilizing nanotechnology rather than chemicals, diluted poisons, or heavy metals, and for a period that lasts 6-12 months, as long as he surface is not worn. Possible applications and targets include facility touch points such as door push-pads and handle wraps, as well as portable mats for counters, tray tables, and bathroom vanities. The surfaces were tested at King Abdul-Aziz University Hospital (KSU; Riyadh, Saudi Arabia) against several types of Gram positive, Gram negative, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
“After receiving the initial test results, we started calling the NanoSeptic products 'Magical Paper' because of their ability to kill bacteria,” said Amr Saeb, PhD, head of biotechnology at KSU. “This product was able to Kill 100% of E. coli and P. aeruginosa and 88% of MRSA germs after only one hour. As a microbial geneticist, I am really excited by the latest approaches to kill pathogens in a safe and environmentally conscious way without generating resistant microbes which are difficult to treat.”
“At NanoTouch, we're so excited that research centers across the globe are validating our ongoing mission—to change the world.” said Dennis Hackemeyer, cofounder of NanoTouch Materials. “Another exciting aspect of NanoSeptic products is the visual communication which has the potential to change behavior. Visitors gravitate toward touching the NanoSeptic surface which keeps other surfaces cleaner.”
Related Links:
Center for Advanced Engineering and Research
NanoTouch Materials
The NanoSeptic surface, developed in the Center for Advanced Engineering and Research (CAER; Forest, VA, USA) and manufactured by NanoTouch Materials (Forest, VA, USA), is composed of antimicrobial components that are molecularly bonded on a nanoscale, providing a nonleaching, self-cleaning surface that constantly traps and kills bacteria, viruses, and fungi through a catalytic oxidation process using available light. The surfaces also eventually degrade the endotoxins the are the result of bacterial death.
The surfaces work constantly kill pathogens utilizing nanotechnology rather than chemicals, diluted poisons, or heavy metals, and for a period that lasts 6-12 months, as long as he surface is not worn. Possible applications and targets include facility touch points such as door push-pads and handle wraps, as well as portable mats for counters, tray tables, and bathroom vanities. The surfaces were tested at King Abdul-Aziz University Hospital (KSU; Riyadh, Saudi Arabia) against several types of Gram positive, Gram negative, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
“After receiving the initial test results, we started calling the NanoSeptic products 'Magical Paper' because of their ability to kill bacteria,” said Amr Saeb, PhD, head of biotechnology at KSU. “This product was able to Kill 100% of E. coli and P. aeruginosa and 88% of MRSA germs after only one hour. As a microbial geneticist, I am really excited by the latest approaches to kill pathogens in a safe and environmentally conscious way without generating resistant microbes which are difficult to treat.”
“At NanoTouch, we're so excited that research centers across the globe are validating our ongoing mission—to change the world.” said Dennis Hackemeyer, cofounder of NanoTouch Materials. “Another exciting aspect of NanoSeptic products is the visual communication which has the potential to change behavior. Visitors gravitate toward touching the NanoSeptic surface which keeps other surfaces cleaner.”
Related Links:
Center for Advanced Engineering and Research
NanoTouch Materials
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Mammography System (Analog)
MAM VENUS
New
Half Apron
Demi
Latest Critical Care News
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
